Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

90 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evaluating the impact of dose reductions and delays on progression-free survival in women with ovarian cancer treated with either three-weekly or dose-dense carboplatin and paclitaxel regimens in the national prospective OPAL cohort study.
Sivakumaran T, Mileshkin L, Grant P, Na L, DeFazio A, Friedlander M, Obermair A, Webb PM, Au-Yeung G; OPAL Study Group. Sivakumaran T, et al. Gynecol Oncol. 2020 Jul;158(1):47-53. doi: 10.1016/j.ygyno.2020.04.706. Epub 2020 May 4. Gynecol Oncol. 2020. PMID: 32381362
A comparison of DNA sequencing and gene expression profiling to assist tissue of origin diagnosis in cancer of unknown primary.
Posner A, Prall OW, Sivakumaran T, Etemadamoghadam D, Thio N, Pattison A, Balachander S, Fisher K, Webb S, Wood C, DeFazio A, Wilcken N, Gao B, Karapetis CS, Singh M, Collins IM, Richardson G, Steer C, Warren M, Karanth N, Wright G, Williams S, George J, Hicks RJ, Boussioutas A, Gill AJ, Solomon BJ, Xu H, Fellowes A, Fox SB, Schofield P, Bowtell D, Mileshkin L, Tothill RW. Posner A, et al. Among authors: sivakumaran t. J Pathol. 2023 Jan;259(1):81-92. doi: 10.1002/path.6022. Epub 2022 Nov 30. J Pathol. 2023. PMID: 36287571 Free PMC article.
Immune and genomic biomarkers of immunotherapy response in cancer of unknown primary.
Posner A, Sivakumaran T, Pattison A, Etemadmoghadam D, Thio N, Wood C, Fisher K, Webb S, DeFazio A, Wilcken N, Gao B, Karapetis CS, Singh M, Collins IM, Richardson G, Steer C, Warren M, Karanth N, Fellowes A, Fox SB, Hicks RJ, Schofield P, Bowtell D, Prall OWJ, Tothill RW, Mileshkin L. Posner A, et al. Among authors: sivakumaran t. J Immunother Cancer. 2023 Jan;11(1):e005809. doi: 10.1136/jitc-2022-005809. J Immunother Cancer. 2023. PMID: 36720497 Free PMC article.
Six-year experience of Australia's first dedicated cancer of unknown primary clinic.
van Mourik A, Tonkin-Hill G, O'Farrell J, Waller S, Tan L, Tothill RW, Bowtell D, Fox S, Fellowes A, Fedele C, Schofield P, Sivakumaran T, Wong HL, Mileshkin L. van Mourik A, et al. Among authors: sivakumaran t. Br J Cancer. 2023 Aug;129(2):301-308. doi: 10.1038/s41416-023-02254-6. Epub 2023 May 24. Br J Cancer. 2023. PMID: 37225894 Free PMC article.
Identifying the primary tumour in patients with cancer of unknown primary (CUP) using [18F]FDG PET/CT: a systematic review and individual patient data meta-analysis.
Willemse JRJ, Lambregts DMJ, Balduzzi S, Schats W, Snaebjornsson P, Marchetti S, Vollebergh MA, van Golen LW, Cheung Z, Vogel WV, Bodalal Z, Rostami S, Gerke O, Sivakumaran T, Beets-Tan RGH, Lahaye MJ. Willemse JRJ, et al. Among authors: sivakumaran t. Eur J Nucl Med Mol Imaging. 2024 Aug 14. doi: 10.1007/s00259-024-06860-1. Online ahead of print. Eur J Nucl Med Mol Imaging. 2024. PMID: 39141069 Review.
Are exercise and sitting time during chemotherapy for ovarian cancer associated with treatment-related side-effects, chemotherapy completion and survival?
Ross TL, Na R, Au-Yeung G, DeFazio A, Friedlander M, Sivakumaran T, Livingstone K AM, Nagle CM, O'Neill H, Williams M, Webb PM, Beesley VL. Ross TL, et al. Among authors: sivakumaran t. Gynecol Oncol. 2024 Nov;190:53-61. doi: 10.1016/j.ygyno.2024.07.684. Epub 2024 Aug 14. Gynecol Oncol. 2024. PMID: 39146755 Free article.
90 results